Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)

Clinical trial NCT04715932 · COMPLETED

Trial details

NCT number: NCT04715932
Sponsor: Montreal Heart Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Anosmia Fever Cough Shortness of Breath Sore Throat Nausea Vomiting Headache Muscle Weakness Pain, Muscle Pain, Chest

Start date: 2021-02-18
Primary completion: 2021-05-25
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.